Roivant, continuing ascent, claims another victory for rare disease drug
Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also be a “best-in-disease” medicine for an inflammatory eye condition, one analyst said.
Sources
- T2Roivant, continuing ascent, claims another victory for rare disease drugBioPharma Dive / Healthcare Dive / MedTech Dive